000 01483 a2200385 4500
005 20250511181346.0
264 0 _c19921123
008 199211s 0 0 eng d
022 _a0732-183X
024 7 _a10.1200/JCO.1992.10.11.1748
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEinzig, A I
245 0 0 _aPhase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cNov 1992
300 _a1748-53 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aMiddle Aged
650 0 4 _aOvarian Neoplasms
_xdrug therapy
650 0 4 _aPaclitaxel
_xadministration & dosage
650 0 4 _aTreatment Outcome
700 1 _aWiernik, P H
700 1 _aSasloff, J
700 1 _aRunowicz, C D
700 1 _aGoldberg, G L
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 10
_gno. 11
_gp. 1748-53
856 4 0 _uhttps://doi.org/10.1200/JCO.1992.10.11.1748
_zAvailable from publisher's website
999 _c1363608
_d1363608